Your NPR news source
Biden's Push to Make Some of the Most Expensive Prescription Drugs Cheaper

US President Joe Biden arrives to speak about lowering healthcare costs during an event in the East Room of the White House in Washington, DC, on August 29, 2023. (Photo by SAUL LOEB / AFP) (Photo by SAUL LOEB/AFP via Getty Images)

SAUL LOEB/AFP via Getty Images

Biden's Push to Make Some of the Most Expensive Prescription Drugs Cheaper

US President Joe Biden arrives to speak about lowering healthcare costs during an event in the East Room of the White House in Washington, DC, on August 29, 2023. (Photo by SAUL LOEB / AFP) (Photo by SAUL LOEB/AFP via Getty Images)

SAUL LOEB/AFP via Getty Images

Biden's Push to Make Some of the Most Expensive Prescription Drugs Cheaper

On Tuesday, the Biden administration released a list of 10 medications that it's planning to negotiate prices for Medicare in an effort to bring down the costs of some of the most expensive drugs. It's part of a reform included in the Inflation Reduction Act. Many on the list are life-saving drugs that treat diabetes, cancer and other major health problems.| The new prices that the federal government will eventually negotiate for these prescription drugs won't actually go into effect until 2026, and that's only if it doesn't get tied up in court with drugmakers. Six pharmaceutical companies who have filed lawsuits against the administration are calling these provisions unconstitutional. Juana Summers speaks with NPR's pharmaceuticals correspondent Sydney Lupkin and Deepa Shivaram at the White House about the battle lines being drawn between the Biden Administration and pharmaceutical companies.

US President Joe Biden arrives to speak about lowering healthcare costs during an event in the East Room of the White House in Washington, DC, on August 29, 2023. (Photo by SAUL LOEB / AFP) (Photo by SAUL LOEB/AFP via Getty Images)

SAUL LOEB/AFP via Getty Images

 

On Tuesday, the Biden administration released a list of 10 medications that it's planning to negotiate prices for Medicare in an effort to bring down the costs of some of the most expensive drugs. It's part of a reform included in the Inflation Reduction Act. Many on the list are life-saving drugs that treat diabetes, cancer and other major health problems.|

The new prices that the federal government will eventually negotiate for these prescription drugs won't actually go into effect until 2026, and that's only if it doesn't get tied up in court with drugmakers. Six pharmaceutical companies who have filed lawsuits against the administration are calling these provisions unconstitutional.

Juana Summers speaks with NPR's pharmaceuticals correspondent Sydney Lupkin and Deepa Shivaram at the White House about the battle lines being drawn between the Biden Administration and pharmaceutical companies.

More From This Show
The Girl Scouts have been part of American childhood for generations. And now that quintessential experience is helping young girls, who are new to the United States get a sense of belonging. It comes through a Girl Scout troop based in one of New York City’s largest migrant shelters. The shelter has around 3,500 migrants, and all of the Girl Scouts are children of families seeking asylum. For the last few weeks, NPR’s Jasmine Garsd has been spending time with them, and brings us their their story. For sponsor-free episodes of Consider This, sign up for Consider This+ via Apple Podcasts or at plus.npr.org. Email us at considerthis@npr.org. Learn more about sponsor message choices: podcastchoices.com/adchoices NPR Privacy Policy